{
  "ticker": "SVRA",
  "company_name": "Savara, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT01746095",
      "title": "Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Cystic Fibrosis",
      "start_date": "2013-03",
      "completion_date": "2014-11",
      "enrollment": 0,
      "sponsor": "Savara Inc."
    },
    {
      "nct_id": "NCT01515007",
      "title": "Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3)",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Non Cystic Fibrosis Bronchiectasis",
      "start_date": "2014-03-31",
      "completion_date": "2016-10",
      "enrollment": 0,
      "sponsor": "Aradigm Corporation"
    },
    {
      "nct_id": "NCT03482752",
      "title": "Safety Extension Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Autoimmune Pulmonary Alveolar Proteinosis",
      "start_date": "2018-04-16",
      "completion_date": "2021-01-14",
      "enrollment": 0,
      "sponsor": "Savara Inc."
    },
    {
      "nct_id": "NCT02468908",
      "title": "Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Pulmonary Alveolar Proteinosis, Bronchiectasis, Cystic Fibrosis, Acute Respiratory Distress Syndrome",
      "start_date": "2015-05",
      "completion_date": "2015-10",
      "enrollment": 0,
      "sponsor": "Savara Inc."
    },
    {
      "nct_id": "NCT06546098",
      "title": "Molgramostim Nebulizer Solution Expanded Access Program Protocol",
      "status": "AVAILABLE",
      "phase": "",
      "condition": "Autoimmune Pulmonary Alveolar Proteinosis",
      "start_date": "",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Savara Inc."
    },
    {
      "nct_id": "NCT03421743",
      "title": "Pilot Trial of Inhaled Molgramostim in Non-tuberculous Mycobacterial (NTM) Infection",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Mycobacterium Infections, Nontuberculous",
      "start_date": "2018-03-01",
      "completion_date": "2020-01-13",
      "enrollment": 0,
      "sponsor": "Savara Inc."
    },
    {
      "nct_id": "NCT02104245",
      "title": "Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4)",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Non Cystic Fibrosis Bronchiectasis",
      "start_date": "2014-05-28",
      "completion_date": "2016-10",
      "enrollment": 0,
      "sponsor": "Aradigm Corporation"
    },
    {
      "nct_id": "NCT06431776",
      "title": "Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).",
      "status": "NOT_YET_RECRUITING",
      "phase": "PHASE3",
      "condition": "Autoimmune Pulmonary Alveolar Proteinosis",
      "start_date": "2024-08",
      "completion_date": "2027-08",
      "enrollment": 0,
      "sponsor": "Savara Inc."
    },
    {
      "nct_id": "NCT01090908",
      "title": "Evaluation of Ciprofloxacin for Inhalation to Cystic Fibrosis Patients With P. Aeruginosa",
      "status": "WITHDRAWN",
      "phase": "",
      "condition": "Cystic Fibrosis",
      "start_date": "2010-09",
      "completion_date": "2011-06",
      "enrollment": 0,
      "sponsor": "Aradigm Corporation"
    },
    {
      "nct_id": "NCT03181932",
      "title": "AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "MRSA, Cystic Fibrosis",
      "start_date": "2017-09-20",
      "completion_date": "2021-01-15",
      "enrollment": 0,
      "sponsor": "Savara Inc."
    }
  ],
  "summary": {
    "total_trials": 14,
    "by_phase": {
      "PHASE2": 4,
      "PHASE3": 6,
      "PHASE1": 2,
      "": 2
    },
    "by_status": {
      "COMPLETED": 8,
      "TERMINATED": 2,
      "AVAILABLE": 1,
      "NOT_YET_RECRUITING": 1,
      "WITHDRAWN": 1,
      "ACTIVE_NOT_RECRUITING": 1
    },
    "active_trials": 1,
    "completed_trials": 8,
    "conditions": [
      "Autoimmune Pulmonary Alveolar Proteinosis",
      "Cystic Fibrosis",
      "Healthy, Cystic Fibrosis",
      "MRSA, Cystic Fibrosis",
      "Mycobacterium Infections, Nontuberculous",
      "Mycobacterium Infections, Nontuberculous, Cystic Fibrosis (CF)",
      "Non Cystic Fibrosis Bronchiectasis",
      "Pulmonary Alveolar Proteinosis, Bronchiectasis, Cystic Fibrosis, Acute Respiratory Distress Syndrome"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:22:11.932067",
    "search_query": "Savara, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Savara,+Inc."
  }
}